News | February 18, 2022
Ligand posts strong 2021 performance
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024
The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru
The entire integration and transition of the brands is expected to be completed by March 2022
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
Subscribe To Our Newsletter & Stay Updated
